MedaSync Secures Strategic Investment from Omega Healthcare Investors, Inc.

Rhea-AI Summary

Omega Healthcare Investors (NYSE:OHI) has made a strategic investment in MedaSync, a provider of AI-powered reimbursement optimization software for skilled nursing facilities. The investment aims to accelerate MedaSync's market penetration and product development in the healthcare sector.

MedaSync has demonstrated strong growth with customer acquisition increasing over 100% year-over-year. The company's cloud-based platform utilizes custom AI-audits to analyze clinical documentation and identify reimbursement misalignments. As part of the deal, Megan Krull, Senior Vice President of Operations at Omega Healthcare, will join MedaSync's Board of Directors.

Positive

• None.

Negative

• Skilled nursing sector faces mounting operational pressures
• Challenging reimbursement landscape in healthcare industry

Investment Accelerates Company's AI-Powered Reimbursement Software Growth in Skilled Nursing

CLEVELAND, Aug. 27, 2025 /PRNewswire/ -- MedaSync, a leading provider of AI-powered reimbursement optimization software for skilled nursing facilities, is proud to announce a strategic investment from Omega Healthcare Investors, Inc. (NYSE: OHI), a premier real estate investment trust focused on skilled nursing and assisted living facilities.

This investment will help MedaSync accelerate the adoption of advanced, intelligent tools designed to reduce administrative burden across the skilled nursing sector. MedaSync is experiencing significant business growth, with customer acquisition increasing more than 100% year-over-year.

Megan Krull, Senior Vice President of Operations of Omega Healthcare Investors, Inc., will join the MedaSync Board of Directors. "We see tremendous value in MedaSync's technology," said Krull. "Their innovative software is helping our operators to proactively address reimbursement inefficiencies. We're excited to help accelerate MedaSync's market penetration and scale the development of new innovative SaaS products."

Skilled nursing providers are facing mounting operational pressures and are continuously challenged to keep pace with regulatory shifts in reimbursement. MedaSync's cloud-based platform uses custom AI-audits to analyze clinical documentation, proactively surfacing reimbursement misalignments and identifying shifting patient/resident needs to help ensure high quality care. MedaSync is the only tailored solution built to enhance an operator's unique reimbursement mix including Medicare, Medicaid CMI, QIP performance and Medicare Advantage. 

"This funding is a powerful endorsement of our vision and achievements in the healthcare industry," said Ryan Edgerly, CEO of MedaSync. "We are excited to partner with Omega to accelerate our growth and continue to provide skilled nursing organizations an innovative solution to thrive in today's challenging reimbursement landscape."

About MedaSync

MedaSync delivers AI-driven reimbursement software to improve revenue efficiency potential across all payers serving skilled nursing organizations. Our machine learning software transforms the reimbursement process through intelligent curated patient summaries that automatically detect reimbursement misalignment and identify potential quality incentive risks customized across every organization's PDPM, CMI, QIP programs and Level-based plans. Hundreds of skilled nursing organizations rely on MedaSync's proactive insights to improve quality of revenue, save staff valuable time, and pinpoint functional decline to improve outcomes. For more information, visit www.medasync.com.

About Omega Healthcare Investors, Inc.

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK. More information on Omega is available at www.omegahealthcare.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/medasync-secures-strategic-investment-from-omega-healthcare-investors-inc-302539971.html

SOURCE MedaSync

FAQ

What is the strategic investment between Omega Healthcare (NYSE:OHI) and MedaSync?

Omega Healthcare Investors has made a strategic investment in MedaSync to accelerate the adoption of AI-powered reimbursement optimization software in skilled nursing facilities. The investment amount was not disclosed.

How fast is MedaSync growing in 2025?

MedaSync is experiencing significant growth with customer acquisition increasing more than 100% year-over-year.

Who will join MedaSync's Board of Directors from Omega Healthcare?

Megan Krull, Senior Vice President of Operations of Omega Healthcare Investors, will join MedaSync's Board of Directors.

What does MedaSync's AI technology do for skilled nursing facilities?

MedaSync's cloud-based platform uses custom AI-audits to analyze clinical documentation, identify reimbursement misalignments, and surface shifting patient needs to ensure high-quality care.

What types of reimbursement does MedaSync's platform handle?

MedaSync's platform is uniquely built to enhance operators' reimbursement mix including Medicare, Medicaid CMI, QIP performance, and Medicare Advantage.